UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000026459
Receipt No. R000030394
Scientific Title Survey on operating room nurse handling anticancer drugs at the time of transurethral bladder tumor resection and efforts towards behavioral change for prevention of anticancer drug exposure
Date of disclosure of the study information 2017/03/09
Last modified on 2018/09/08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Survey on operating room nurse handling anticancer drugs at the time of transurethral bladder tumor resection and efforts towards behavioral change for prevention of anticancer drug exposure
Acronym Survey on operating room nurse handling anticancer drugs at the time of transurethral bladder tumor resection and efforts towards behavioral change for prevention of anticancer drug exposure
Scientific Title Survey on operating room nurse handling anticancer drugs at the time of transurethral bladder tumor resection and efforts towards behavioral change for prevention of anticancer drug exposure
Scientific Title:Acronym Survey on operating room nurse handling anticancer drugs at the time of transurethral bladder tumor resection and efforts towards behavioral change for prevention of anticancer drug exposure
Region
Japan

Condition
Condition bladder cancer
Classification by specialty
Urology Nursing
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 I will investigate the treatment of anticancer drugs by the operating room nurse at the time of transurethral bladder tumor resection and clarify the actual situation.
Basic objectives2 Others
Basic objectives -Others We will conduct preventive education for anticancer agent exposure prevention and aim to change behavior so that safe anti-cancer drug handling.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Questionnaire operating room nurse's how to handle anticancer agent.
Questionnaire is done before prevention education, immediately after preventive education, six months after preventive education.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Educational,Counseling,Training
Type of intervention
Behavior,custom Maneuver
Interventions/Control_1 Prevention education. Lecture and exercise.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
21 years-old <
Age-upper limit
46 years-old >=
Gender Male and Female
Key inclusion criteria A nurse enrolled in the operation section
Key exclusion criteria Administrator,Nurse while taking childcare leave and during prenatal postpartum vacation
Target sample size 30

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Tomomi Suzuki
Organization Tokyo Medical and Dental University hospital
Division name Surgery department
Zip code
Address 1-5-45 Yushima, Bunkyo-ku, Tokyo
TEL 03-5803-6111
Email 0372mnrs@tmd.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Tomomi Suzuki
Organization Tokyo Medical and Dental University hospital
Division name Surgery department
Zip code
Address 1-5-45 Yushima, Bunkyo-ku, Tokyo
TEL 03-5803-5632
Homepage URL
Email 0372mnrs@tmd.ac.jp

Sponsor
Institute Tokyo Medical and Dental University
Institute
Department

Funding Source
Organization Tokyo Medical and Dental University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 03 Month 09 Day

Related information
URL releasing protocol
Publication of results Published

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 02 Month 28 Day
Date of IRB
Anticipated trial start date
2017 Year 03 Month 09 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
2018 Year 06 Month 16 Day

Other
Other related information

Management information
Registered date
2017 Year 03 Month 08 Day
Last modified on
2018 Year 09 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030394

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.